EU-OPENSCREEN - AUTUMN TRAINING SCHOOL 2022

We are very happy to present the 2022 edition of our online AUTUMN TRAINING SCHOOL!

Target group: Everyone with an interest in science although young scientists are preferably welcomed for a great opportunity to meet distinguished speakers and discuss scientific, but also career questions, during the training school Q&A sessions.

Participation fee: free of charge

Registration deadline: November 8th 2022

This autumn school receives funding from the European Union´s Horizon 2020 research and innovation programme under grant agreement No 823893 (EU-OPENSCREEN-DRIVE).

Topics

This second edition of our training school will present various aspects of chemical biology

Starting with a general introduction to the field, we will continue by exploring more specific subjects such as

  • High Throughput Screening (HTS)
  • Hit selection 
  • Cheminformatics 
  • Medicinal chemistry 
  • Principles of open data and open-source tools
  • Assay development and optimisation 
  • Data analysis/ data reproducibility
  • Screening automation 
  • Chemical proteomics .

In this year's EU-OPENSCREEN Autumns School also representatives from the industrial sector will share their knowledge and expertise on the latest advances in HTS and test development.

Schedule

Monday - November 14, 2022

EU-OPENSCREEN ERIC Screening and Medicinal Chemistry Services

Wolfgang Fecke 

Director General EU-OPENSCREEN ERIC, Coordinator EU-OPENSCREEN-DRIVE, Germany

Strategies on medicinal chemistry: Drug discovery and development

Ana Martinez

Centro de Investigaciones Biológicas Margarita Salas (CSIC), Spain

Break (15')

Making data FAIR - a great way to increase the impact of your research

Phil Gribbon

Head of Hamburg Location, Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Hamburg

Lunch Break (75')

Hit Selection

Johannes Landskron

Norwegian Center for Molecular Medicine (NCMM) at Oslo University (UiO), Norway

 

Tuesday - November 15, 2022

Introduction to Cheminformatics

Daniel Svozil

Institute of Molecular Genetics of the Czech Academy of Sciences (IMG), Czech Republic

The European Chemical Biology Database (ECBD)

Tomas Muller

Institute of Molecular Genetics of the Czech Academy of Sciences (IMG), Czech Republic

Break (15')

Assay Development and Compound Profiling in Drug Discovery

Thomas Lundbäck

Senior Director, Mechanistic & Structural Biology, Discovery Sciences, R&D, AstraZeneca, Sweden

Lunch Break (75')

High throughput screening with natural products libraries

Olga Genilloud

Scientific Director Fundación MEDINA, Spain

 

Wednesday - November 16, 2022

Designing chemical probes for serine hydrolases

Rui Moreira

President of the European Federation for Medicinal Chemistry (EFMC), Research Institute for Medicine (imed), Portugal

Assay development and optimization

Pepo Brea

University of Santiago de Compostela (USC), Spain

Break (15')

Chemical proteomics

Guillaume Médard

TUM School of Life Sciences, Technical University of Munich, Germany

Lunch Break (75')

Quantifying Target Engagement in Cells with NanoBRET probes

Matthew Robers

Promega Corporation

 

Thursday - November 17, 2022

Introduction to the translational development pipeline – from idea to the patient

Rebecca Ludwig, Alicia Soler

EATRIS | European infrastructure for translational medicine

Mechanism of Action and Target Identification Studies

Brinton Seashore-Ludlow

Chemical Biology Consortium Sweden (CBCS)

Break (15')

A toolkit towards the design of antimetastatic advanced therapies

Maria J. Vicent

Centro de Investigación príncipe Felipe, Spain

Lunch Break (75')

Drug sensitivity and resistance testing

Jani Saarela

Institute for Molecular Medicine Finland (FIMM)

 

Friday - November 18, 2022

Optimizing the biological profile of compounds in the drug discovery process

Sheraz Gul

Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Germany

General introduction to chemical biology

Mabel Loza, Maria Joao Matos 

University of Santiago de Compostela (USC), Spain

Break (15')

Screening automation

Martin Neuenschwander 

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Germany 

Lunch Break (75')

Using QC purity + identity assessment to enhance data reproducibility and reliability

Federica Rossella

EU-OPENSCREEN ERIC, Germany